Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dechu Puliyanda

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Pediatric Nephrology (Berlin, Germany)|April 7, 2016
Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejectionMeghan H Pearl, Anjali B Nayak, Robert B Ettenger, et al.
Transplantation|April 2, 2014
Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximabDebora Barbosa, Joseph Kahwaji, Dechu Puliyanda, et al.
Transplantation|January 22, 2015
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patientsAshley A Vo, Adriana Zeevi, Jua Choi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplantation|May 29, 2015
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize PatientsAshley A Vo, Jua Choi, Irene Kim, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Pediatric Transplantation|April 11, 2024
Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research ConsortiumIsa F Ashoor, Rachel M Engen, Dechu Puliyanda, et al.
Clinical Transplantation|June 3, 2022
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipientsMeghan Pearl, Patricia L Weng, Lucia Chen, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Pediatric Nephrology (Berlin, Germany)|April 7, 2016
Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejectionMeghan H Pearl, Anjali B Nayak, Robert B Ettenger, et al.
Transplantation|April 2, 2014
Polyomavirus BK viremia in kidney transplant recipients after desensitization with IVIG and rituximabDebora Barbosa, Joseph Kahwaji, Dechu Puliyanda, et al.
Transplantation|January 22, 2015
A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patientsAshley A Vo, Adriana Zeevi, Jua Choi, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 12, 2018
A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipientsStanley C Jordan, Jua Choi, Olivier Aubert, et al.
Transplantation|May 29, 2015
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize PatientsAshley A Vo, Jua Choi, Irene Kim, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Pediatric Transplantation|April 11, 2024
Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research ConsortiumIsa F Ashoor, Rachel M Engen, Dechu Puliyanda, et al.
Clinical Transplantation|June 3, 2022
Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipientsMeghan Pearl, Patricia L Weng, Lucia Chen, et al.
Pageof 3